"Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom: uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej. W procesie badania klinicznego najważniejszym ogniwem jest pacjent, jego komfort oraz bezpieczeństwo."

During the past decade, Centrum Medyczne Pratia Katowice conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Pratia Katowice" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Anji Pharma" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Katowice" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Katowice" are "Rheumatoid Arthritis" (4 trials), "Diabetes Mellitus, Type 2" (2 trials), "Parkinson's Disease" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Katowice" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Pratia Katowice" are "Drug" (20 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Baricitinib" (4 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "ABP 654" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Pratia Katowice" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Medyczne Pratia Katowice". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centrum Medyczne Pratia Katowice, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Pratia Katowice, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".